BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Serbati N, Senhaji N, Diakite B, Badre W, Nadifi S. IL23R and ATG16L1 variants in Moroccan patients with inflammatory bowel disease. BMC Res Notes. 2014;7:570. [PMID: 25159710 DOI: 10.1186/1756-0500-7-570] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
Number Citing Articles
1 Floss DM, Schröder J, Franke M, Scheller J. Insights into IL-23 biology: From structure to function. Cytokine Growth Factor Rev 2015;26:569-78. [PMID: 26195433 DOI: 10.1016/j.cytogfr.2015.07.005] [Cited by in Crossref: 64] [Cited by in F6Publishing: 63] [Article Influence: 9.1] [Reference Citation Analysis]
2 Hodges P, Kelly P. Inflammatory bowel disease in Africa: what is the current state of knowledge? Int Health 2020;12:222-30. [PMID: 32133502 DOI: 10.1093/inthealth/ihaa005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Qiao YQ, Huang ML, Zheng Q, Wang TR, Xu AT, Cao Y, Zhao D, Ran ZH, Shen J. CNTNAP3 associated ATG16L1 expression and Crohn's disease. Mediators Inflamm 2015;2015:404185. [PMID: 25883416 DOI: 10.1155/2015/404185] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
4 Zhang BB, Liang Y, Yang B, Tan YJ. Association between ATG16L1 gene polymorphism and the risk of Crohn's disease. J Int Med Res 2017;45:1636-50. [PMID: 27698206 DOI: 10.1177/0300060516662404] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
5 Senhaji N, Serrano A, Badre W, Serbati N, Karkouri M, Zaid Y, Nadifi S, Martin J. Association of inflammatory cytokine gene polymorphisms with inflammatory bowel disease in a Moroccan cohort. Genes Immun. 2016;17:60-65. [PMID: 26632999 DOI: 10.1038/gene.2015.52] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
6 Limanskiy V, Vyas A, Chaturvedi LS, Vyas D. Harnessing the potential of gene editing technology using CRISPR in inflammatory bowel disease. World J Gastroenterol 2019; 25(18): 2177-2187 [PMID: 31143069 DOI: 10.3748/wjg.v25.i18.2177] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
7 Diler SB, Polat F, Yaraş S. The P268S and M863V Polymorphisms of the NOD2/CARD15 Gene in Crohn’s Disease and Ulcerative Colitis. Cytol Genet 2019;53:424-9. [DOI: 10.3103/s0095452719050074] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
8 Gil J, Pesz KA, Sąsiadek MM. May autophagy be a novel biomarker and antitumor target in colorectal cancer? Biomark Med 2016;10:1081-94. [PMID: 27626110 DOI: 10.2217/bmm-2016-0083] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
9 Senhaji N, Diakité B, Serbati N, Zaid Y, Badre W, Nadifi S. Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms: New data and a meta-analysis. BMC Gastroenterol 2014;14:206. [PMID: 25492126 DOI: 10.1186/s12876-014-0206-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
10 Budak Diler S, Aybuğa F. Association of Autophagy Gene ATG16L1 Polymorphism with Human Prostate Cancer and Bladder Cancer in Turkish Population. Asian Pac J Cancer Prev 2018;19:2625-30. [PMID: 30256070 DOI: 10.22034/APJCP.2018.19.9.2625] [Cited by in F6Publishing: 2] [Reference Citation Analysis]